Steven J. Chartier

Steven J. Chartier

Chief Operating Officer at BioVentrix, Inc.

55 year
Health Technology
Health Services
Consumer Services

Profile

Steven J.
Chartier
is currently the Chief Operating Officer at BioVentrix, Inc. and a Member at Regulatory Affairs Professionals Society.
He previously worked as the Director of Regulatory Affairs at NUCRYST Pharmaceuticals Corp.
from 2009 to 2013, Manager of Clinical Projects at Biogen, Inc., Vice President of Operations and Regulatory Affairs at Infraredx, Inc. in 2013, VP of Regulatory Affairs and Regulatory Affairs at Augmenix, Inc., Principal at Dana-Farber Cancer Institute, Inc., Coordinator of Clinical Trials at Beth Israel Deaconess Medical Center, Inc., and Chief Operating Officer at PixarBio Corp.
from 2016 to 2017.
Mr. Chartier received his undergraduate degree from St. Anselm College.

Steven J. Chartier active positions

CompaniesPositionStart
Corporate Officer/Principal -
Chief Operating Officer -
All active positions of Steven J. Chartier

Former positions of Steven J. Chartier

CompaniesPositionEnd
ANIKA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2017-12-31
PIXARBIO CORPORATION Chief Operating Officer 2017-02-01
General Counsel -
Corporate Officer/Principal -
General Counsel -
See the detail of Steven J. Chartier's experience

Training of Steven J. Chartier

St. Anselm College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven J. Chartier's experience

Connections

90

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ANIKA THERAPEUTICS, INC.

Health Technology

BIOGEN INC.

Health Technology

PIXARBIO CORPORATION

Consumer Services

Private companies7

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Steven J. Chartier
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW